文献速递甲状腺疾病

含碘产前多种微量营养素对母婴碘状态及甲状腺功能的影响:冈比亚随机试验

Effects of an Iodine-Containing Prenatal Multiple Micronutrient on Maternal and Infant Iodine Status and Thyroid Function: A Randomized Trial in The Gambia.
PubMed 文献 · Thyroid · 2020-04-28

在冈比亚农村中度碘缺乏人群中,孕妇随机接受含300 μg碘的多种微量营养素或铁叶酸补充,含碘组母体尿碘浓度升高、母体及脐血甲状腺球蛋白降低,但母体甲状腺功能指标和母乳碘浓度无差异;产后12周时两组碘营养仍不足。

要点

  • 含碘多种微量营养素可提高中度碘缺乏孕妇的尿碘浓度并降低甲状腺球蛋白。
  • 补充对母体TSH、TT3、TT4及母乳碘浓度无显著影响。
  • 产后12周时母体尿碘、婴儿甲状腺球蛋白及母乳碘浓度两组无差异,碘营养仍不充足。

核心结论

  • 对中度碘缺乏孕妇补充含碘多种微量营养素可改善母体碘状态并降低甲状腺球蛋白浓度,但产后未维持效果,出生后前6个月母婴碘营养仍不充足。

研究设计与样本

  • 研究使用在冈比亚Keneba开展的随机对照试验ENID(ISRCTN49285450)的数据和样本,孕妇(<20周妊娠)随机接受每日含300 μg碘的多种微量营养素或铁叶酸补充,随机化双盲(参与者和研究者)。
  • 本二次分析纳入多种微量营养素组(n=219)和铁叶酸组(n=219)孕妇,共875名孕妇于2010年4月至2015年2月入组。

主要发现

  • 基线时母体尿碘浓度中位数(四分位距)为51 μg/L(33-82),甲状腺球蛋白为22 μg/L(12-39),提示中度碘缺乏。
  • 与铁叶酸组相比,多种微量营养素组母体尿碘浓度升高(p<0.001)、母体甲状腺球蛋白降低(p<0.001)、脐血甲状腺球蛋白降低(p<0.001)。
  • 研究期间母体甲状腺功能指标(TSH、TT3、TT4及TT3/TT4比值)和母乳碘浓度在两组间无差异。
  • 产后12周时多种微量营养素组母乳碘浓度中位数(四分位距)为51 μg/L(35-72)、母体尿碘浓度为39 μg/L(25-64)、婴儿甲状腺球蛋白为87 μg/L(59-127),两组间无差异。

临床怎么用

  • 作者认为,在中度碘缺乏人群中应考虑确保妊娠期和哺乳期获得充足的母体碘状态。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Iodine supplementation is recommended to pregnant women in iodine-deficient populations, but the impact in moderate iodine deficiency is uncertain. We assessed the effect of an iodine-containing prenatal multiple micronutrient (MMN) supplement in a rural Gambian population at risk of moderate iodine deficiency. Materials and Methods: This study uses data and samples collected as a part of the randomized controlled trial Early Nutrition and Immune Development (ENID; ISRCTN49285450) conducted in Keneba, The Gambia. Pregnant women (<20 weeks gestation) were randomized to either a daily supplement of MMNs containing 300 μg of iodine or an iron and folic acid (FeFol) supplement. Randomization was double blinded (participants and investigators). The coprimary outcomes were maternal urinary iodine concentration (UIC) and serum thyroglobulin (Tg), assessed at baseline and at 30 weeks' gestation. Secondary outcomes were maternal serum thyrotropin (TSH), total triiodothyronine (TT3), total thyroxine (TT4) (assessed at baseline and at 30 weeks' gestation), breast milk iodine concentration (BMIC) (assessed at 8, 12, and 24 weeks postpartum), infant serum Tg (assessed at birth [cord], 12, and 24 weeks postpartum), and serum TSH (assessed at birth [cord]). The effect of supplementation was evaluated using mixed effects models. Results: A total of 875 pregnant women were enrolled between April 2010 and February 2015. In this secondary analysis, we included women from the MMN (n = 219) and FeFol (n = 219) arm of the ENID trial. At baseline, median (interquartile range or IQR) maternal UIC and Tg was 51 μg/L (33-82) and 22 μg/L (12-39), respectively, indicating moderate iodine deficiency. Maternal MMN supplement increased maternal UIC (p < 0.001), decreased maternal Tg (p < 0.001), and cord blood Tg (p < 0.001) compared with FeFol. Maternal thyroid function tests (TSH, TT3, TT4, and TT3/TT4 ratio) and BMIC did not differ according to maternal supplement group over the course of the study. Median (IQR) BMIC, maternal UIC, and infant Tg in the MMN group were 51 μg/L (35-72), 39 μg/L (25-64), and 87 μg/L (59-127), respectively, at 12 weeks postpartum, and did not differ between supplement groups. Conclusions: Supplementing moderately iodine-deficient women during pregnancy improved maternal iodine status and reduced Tg concentration. However, the effects were not attained postpartum and maternal and infant iodine nutrition remained inadequate during the first six months after birth. Consideration should be given to ensuring adequate maternal status through pregnancy and lactation in populations with moderate deficiency.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Eriksen KG, Andersson M, Hunziker S, et al. Effects of an Iodine-Containing Prenatal Multiple Micronutrient on Maternal and Infant Iodine Status and Thyroid Function: A Randomized Trial in The Gambia. Thyroid. 2020. PMID: 32183608. doi:10.1089/thy.2019.0789

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。